Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 319

1.

An experimental investigation of head loss through a triangular "V- shaped" screen.

Zayed M, El Molla A, Sallah M.

J Adv Res. 2017 Dec 27;10:69-76. doi: 10.1016/j.jare.2017.12.005. eCollection 2018 Mar.

2.

Metal-Adapted Bacteria Isolated From Wastewaters Produce Biofilms by Expressing Proteinaceous Curli Fimbriae and Cellulose Nanofibers.

Mosharaf MK, Tanvir MZH, Haque MM, Haque MA, Khan MAA, Molla AH, Alam MZ, Islam MS, Talukder MR.

Front Microbiol. 2018 Jun 25;9:1334. doi: 10.3389/fmicb.2018.01334. eCollection 2018.

3.

Determination of Aflatoxins in Edible Oils from China and Ethiopia Using Immunoaffinity Column and HPLC-MS/MS.

Chen L, Molla AE, Getu KM, Ma A, Wan C.

J AOAC Int. 2018 Jun 26. doi: 10.5740/jaoacint.18-0106. [Epub ahead of print]

PMID:
29945695
4.
5.

Draft Genome Sequence of Bacillus cereus CITVM-11.1, a Strain Exhibiting Interesting Antifungal Activities.

Caballero J, Peralta C, Molla A, Del Valle EE, Caballero P, Berry C, Felipe V, Yaryura P, Palma L.

J Mol Microbiol Biotechnol. 2018;28(1):47-51. doi: 10.1159/000487597. Epub 2018 Apr 25.

PMID:
29694975
6.

Detoxification of textile effluent by fungal treatment and its performance in agronomic usages.

Molla AH, Khan HI.

Environ Sci Pollut Res Int. 2018 Apr;25(11):10820-10828. doi: 10.1007/s11356-018-1361-3. Epub 2018 Feb 3.

PMID:
29397501
7.

Synthesis and Biological Characterization of Aryl Uracil Inhibitors of Hepatitis C Virus NS5B Polymerase: Discovery of ABT-072, a trans-Stilbene Analog with Good Oral Bioavailability.

Randolph JT, Krueger AC, Donner PL, Pratt JK, Liu D, Motter CE, Rockway TW, Tufano MD, Wagner R, Lim HB, Beyer JM, Mondal R, Panchal NS, Colletti L, Liu Y, Koev G, Kati WM, Hernandez LE, Beno DWA, Longenecker KL, Stewart KD, Dumas EO, Molla A, Maring CJ.

J Med Chem. 2018 Feb 8;61(3):1153-1163. doi: 10.1021/acs.jmedchem.7b01630. Epub 2018 Jan 25.

PMID:
29342358
8.

Who pays for healthcare in Bangladesh? An analysis of progressivity in health systems financing.

Molla AA, Chi C.

Int J Equity Health. 2017 Sep 6;16(1):167. doi: 10.1186/s12939-017-0654-3.

9.

Clinical outcome and risk factors of neonatal sepsis among neonates in Felege Hiwot referral Hospital, Bahir Dar, Amhara Regional State, North West Ethiopia 2016: a retrospective chart review.

Tewabe T, Mohammed S, Tilahun Y, Melaku B, Fenta M, Dagnaw T, Belachew A, Molla A, Belete H.

BMC Res Notes. 2017 Jul 11;10(1):265. doi: 10.1186/s13104-017-2573-1.

10.

TPP-dendrimer nanocarriers for siRNA delivery to the pulmonary epithelium and their dry powder and metered-dose inhaler formulations.

Bielski E, Zhong Q, Mirza H, Brown M, Molla A, Carvajal T, da Rocha SRP.

Int J Pharm. 2017 Jul 15;527(1-2):171-183. doi: 10.1016/j.ijpharm.2017.05.046. Epub 2017 May 23.

PMID:
28549971
11.

Unsuccessful mitosis in multicellular tumour spheroids.

Molla A, Couvet M, Coll JL.

Oncotarget. 2017 Apr 25;8(17):28769-28784. doi: 10.18632/oncotarget.15673.

12.
13.

Predictors of high out-of-pocket healthcare expenditure: an analysis using Bangladesh household income and expenditure survey, 2010.

Molla AA, Chi C, Mondaca AL.

BMC Health Serv Res. 2017 Jan 31;17(1):94. doi: 10.1186/s12913-017-2047-0.

14.

Early Effector T Lymphocytes Coexpress Multiple Inhibitory Receptors in Primary Non-Small Cell Lung Cancer.

Tassi E, Grazia G, Vegetti C, Bersani I, Bertolini G, Molla A, Baldassari P, Andriani F, Roz L, Sozzi G, Pastorino U, Mortarini R, Anichini A.

Cancer Res. 2017 Feb 15;77(4):851-861. doi: 10.1158/0008-5472.CAN-16-1387. Epub 2016 Dec 15.

15.
16.

Cells to Surgery Quiz: April 2016.

Samarkandy SJ, Aldahan AS, Mlacker S, Shah VV, Hsu VM, Molla A, Nouri K.

J Invest Dermatol. 2016 Apr;136(4):e41. No abstract available.

17.

Availability and utilization of medical devices in Jimma zone hospitals, Southwest Ethiopia: a case study.

Ademe BW, Tebeje B, Molla A.

BMC Health Serv Res. 2016 Jul 19;16:287. doi: 10.1186/s12913-016-1523-2.

18.

Cells to Surgery Quiz: March 2016.

Shah VV, Aldahan AS, Mlacker S, Samarkandy S, Molla A, Nouri K.

J Invest Dermatol. 2016 Mar;136(3):e31-2. No abstract available.

19.

Job related stress among nurses working in Jimma Zone public hospitals, South West Ethiopia: a cross sectional study.

Dagget T, Molla A, Belachew T.

BMC Nurs. 2016 Jun 16;15:39. doi: 10.1186/s12912-016-0158-2. eCollection 2016.

20.
21.

Bridging bronchus, type six, as a new rare case of a bronchial anomaly.

El-Molla A, Daabiss M, Al-Otaibi R, Al-Qudaihy H, Bawazir S.

JA Clin Rep. 2016;2(1):44. doi: 10.1186/s40981-016-0070-5. Epub 2016 Dec 7.

22.

Primary cross-resistance to BRAFV600E-, MEK1/2- and PI3K/mTOR-specific inhibitors in BRAF-mutant melanoma cells counteracted by dual pathway blockade.

Penna I, Molla A, Grazia G, Cleris L, Nicolini G, Perrone F, Picciani B, Del Vecchio M, de Braud F, Mortarini R, Anichini A.

Oncotarget. 2016 Jan 26;7(4):3947-65. doi: 10.18632/oncotarget.6600.

23.

NFATc2 is an intrinsic regulator of melanoma dedifferentiation.

Perotti V, Baldassari P, Molla A, Vegetti C, Bersani I, Maurichi A, Santinami M, Anichini A, Mortarini R.

Oncogene. 2016 Jun 2;35(22):2862-72. doi: 10.1038/onc.2015.355. Epub 2015 Sep 21.

PMID:
26387540
24.
25.

Optimization of process parameters for pilot-scale liquid-state bioconversion of sewage sludge by mixed fungal inoculation.

Rahman RA, Molla AH, Barghash HF, Fakhru'l-Razi A.

Environ Technol. 2016;37(1):1-15. doi: 10.1080/09593330.2015.1058860. Epub 2015 Jul 1.

PMID:
26111620
26.

Impact of industrial effluent on growth and yield of rice (Oryza sativa L.) in silty clay loam soil.

Anwar Hossain M, Rahman GK, Rahman MM, Molla AH, Mostafizur Rahman M, Khabir Uddin M.

J Environ Sci (China). 2015 Apr 1;30:231-40. doi: 10.1016/j.jes.2014.10.008. Epub 2015 Feb 3.

PMID:
25872732
27.

DNA mediated assembly of quantum dot-protoporphyrin IX FRET probes and the effect of FRET efficiency on ROS generation.

Singh S, Chakraborty A, Singh V, Molla A, Hussain S, Singh MK, Das P.

Phys Chem Chem Phys. 2015 Feb 28;17(8):5973-81. doi: 10.1039/c4cp05306k.

PMID:
25639515
28.

In vitro activity and resistance profile of dasabuvir, a nonnucleoside hepatitis C virus polymerase inhibitor.

Kati W, Koev G, Irvin M, Beyer J, Liu Y, Krishnan P, Reisch T, Mondal R, Wagner R, Molla A, Maring C, Collins C.

Antimicrob Agents Chemother. 2015 Mar;59(3):1505-11. doi: 10.1128/AAC.04619-14. Epub 2014 Dec 22.

29.

In vitro and in vivo antiviral activity and resistance profile of ombitasvir, an inhibitor of hepatitis C virus NS5A.

Krishnan P, Beyer J, Mistry N, Koev G, Reisch T, DeGoey D, Kati W, Campbell A, Williams L, Xie W, Setze C, Molla A, Collins C, Pilot-Matias T.

Antimicrob Agents Chemother. 2015 Feb;59(2):979-87. doi: 10.1128/AAC.04226-14. Epub 2014 Dec 1.

30.

In vitro and in vivo antiviral activity and resistance profile of the hepatitis C virus NS3/4A protease inhibitor ABT-450.

Pilot-Matias T, Tripathi R, Cohen D, Gaultier I, Dekhtyar T, Lu L, Reisch T, Irvin M, Hopkins T, Pithawalla R, Middleton T, Ng T, McDaniel K, Or YS, Menon R, Kempf D, Molla A, Collins C.

Antimicrob Agents Chemother. 2015 Feb;59(2):988-97. doi: 10.1128/AAC.04227-14. Epub 2014 Dec 1.

31.

Predictors of willingness to participate in health insurance services among the community of jimma town, southwest ethiopia.

Molla A, Fentahun N.

Health Serv Insights. 2014 Oct 23;7:31-7. doi: 10.4137/HSI.S18046. eCollection 2014.

32.

In vitro high throughput screening, what next? Lessons from the screening for aurora kinase inhibitors.

Hoang TM, Vu HL, Le LT, Nguyen CH, Molla A.

Biology (Basel). 2014 Feb 27;3(1):167-75. doi: 10.3390/biology3010167.

33.

Multi-kinase inhibitor C1 triggers mitotic catastrophe of glioma stem cells mainly through MELK kinase inhibition.

Minata M, Gu C, Joshi K, Nakano-Okuno M, Hong C, Nguyen CH, Kornblum HI, Molla A, Nakano I.

PLoS One. 2014 Apr 16;9(4):e92546. doi: 10.1371/journal.pone.0092546. eCollection 2014.

34.

Discovery of ABT-267, a pan-genotypic inhibitor of HCV NS5A.

DeGoey DA, Randolph JT, Liu D, Pratt J, Hutchins C, Donner P, Krueger AC, Matulenko M, Patel S, Motter CE, Nelson L, Keddy R, Tufano M, Caspi DD, Krishnan P, Mistry N, Koev G, Reisch TJ, Mondal R, Pilot-Matias T, Gao Y, Beno DW, Maring CJ, Molla A, Dumas E, Campbell A, Williams L, Collins C, Wagner R, Kati WM.

J Med Chem. 2014 Mar 13;57(5):2047-57. doi: 10.1021/jm401398x. Epub 2014 Jan 15.

PMID:
24400777
35.

Denaturation of bovine spleen galectin-1 in guanidine hydrochloride and fluoroalcohols: structural characterization and implications for protein folding.

Mandal P, Molla AR, Mandal DK.

J Biochem. 2013 Dec;154(6):531-40. doi: 10.1093/jb/mvt084. Epub 2013 Sep 13.

PMID:
24037640
36.

Assessment of sewage sludge bioremediation at different hydraulic retention times using mixed fungal inoculation by liquid-state bioconversion.

Rahman RA, Molla AH, Fakhru'l-Razi A.

Environ Sci Pollut Res Int. 2014 Jan;21(2):1178-87. doi: 10.1007/s11356-013-1974-5. Epub 2013 Jul 24.

PMID:
23881591
37.

High potency improvements to weak aryl uracil HCV polymerase inhibitor leads.

Donner P, Randolph JT, Huang P, Wagner R, Maring C, Lim BH, Colletti L, Liu Y, Mondal R, Beyer J, Koev G, Marsh K, Beno D, Longenecker K, Pilot-Matias T, Kati W, Molla A, Kempf D.

Bioorg Med Chem Lett. 2013 Aug 1;23(15):4367-9. doi: 10.1016/j.bmcl.2013.05.078. Epub 2013 Jun 4.

PMID:
23791079
38.

Aryl uracil inhibitors of hepatitis C virus NS5B polymerase: synthesis and characterization of analogs with a fused 5,6-bicyclic ring motif.

Krueger AC, Randolph JT, DeGoey DA, Donner PL, Flentge CA, Hutchinson DK, Liu D, Motter CE, Rockway TW, Wagner R, Beno DW, Koev G, Lim HB, Beyer JM, Mondal R, Liu Y, Kati WM, Longenecker KL, Molla A, Stewart KD, Maring CJ.

Bioorg Med Chem Lett. 2013 Jun 15;23(12):3487-90. doi: 10.1016/j.bmcl.2013.04.057. Epub 2013 May 1.

PMID:
23664214
39.

Discovery of pyrido[2,3-d]pyrimidine-based inhibitors of HCV NS5A.

DeGoey DA, Betebenner DA, Grampovnik DJ, Liu D, Pratt JK, Tufano MD, He W, Krishnan P, Pilot-Matias TJ, Marsh KC, Molla A, Kempf DJ, Maring CJ.

Bioorg Med Chem Lett. 2013 Jun 15;23(12):3627-30. doi: 10.1016/j.bmcl.2013.04.009. Epub 2013 Apr 10.

PMID:
23642966
40.

Basal aurora kinase B activity is sufficient for histone H3 phosphorylation in prophase.

Le LT, Vu HL, Nguyen CH, Molla A.

Biol Open. 2013 Feb 14;2(4):379-86. doi: 10.1242/bio.20133079. Print 2013 Apr 15.

41.

Study on heavy metals levels and its risk assessment in some edible fishes from Bangshi River, Savar, Dhaka, Bangladesh.

Rahman MS, Molla AH, Saha N, Rahman A.

Food Chem. 2012 Oct 15;134(4):1847-54. doi: 10.1016/j.foodchem.2012.03.099. Epub 2012 Mar 30.

PMID:
23442629
42.

Using ArcMap, Google Earth, and Global Positioning Systems to select and locate random households in rural Haiti.

Wampler PJ, Rediske RR, Molla AR.

Int J Health Geogr. 2013 Jan 18;12:3. doi: 10.1186/1476-072X-12-3.

43.

Hydrosoluble benzo[e]pyridoindolones as potent inhibitors of aurora kinases.

Le LT, Vu HL, Naud-Martin D, Bombled M, Nguyen CH, Molla A.

ChemMedChem. 2013 Feb;8(2):289-96. doi: 10.1002/cmdc.201200479. Epub 2012 Dec 28.

PMID:
23281044
44.
45.

NFATc2 is a potential therapeutic target in human melanoma.

Perotti V, Baldassari P, Bersani I, Molla A, Vegetti C, Tassi E, Dal Col J, Dolcetti R, Anichini A, Mortarini R.

J Invest Dermatol. 2012 Nov;132(11):2652-60. doi: 10.1038/jid.2012.179. Epub 2012 Jun 21.

46.

AMPK activators inhibit the proliferation of human melanomas bearing the activated MAPK pathway.

Petti C, Vegetti C, Molla A, Bersani I, Cleris L, Mustard KJ, Formelli F, Hardie GD, Sensi M, Anichini A.

Melanoma Res. 2012 Oct;22(5):341-50. doi: 10.1097/CMR.0b013e3283544929.

PMID:
22588166
47.

Role of Apollon in human melanoma resistance to antitumor agents that activate the intrinsic or the extrinsic apoptosis pathways.

Tassi E, Zanon M, Vegetti C, Molla A, Bersani I, Perotti V, Pennati M, Zaffaroni N, Milella M, Ferrone S, Carlo-Stella C, Gianni AM, Mortarini R, Anichini A.

Clin Cancer Res. 2012 Jun 15;18(12):3316-27. doi: 10.1158/1078-0432.CCR-11-2232. Epub 2012 May 2.

48.

Identification of aryl dihydrouracil derivatives as palm initiation site inhibitors of HCV NS5B polymerase.

Liu Y, Lim BH, Jiang WW, Flentge CA, Hutchinson DK, Madigan DL, Randolph JT, Wagner R, Maring CJ, Kati WM, Molla A.

Bioorg Med Chem Lett. 2012 Jun 1;22(11):3747-50. doi: 10.1016/j.bmcl.2012.04.017. Epub 2012 Apr 10.

PMID:
22542020
49.

Novel hepatitis C virus replicon inhibitors: synthesis and structure-activity relationships of fused pyrimidine derivatives.

Krueger AC, Madigan DL, Beno DW, Betebenner DA, Carrick R, Green BE, He W, Liu D, Maring CJ, McDaniel KF, Mo H, Molla A, Motter CE, Pilot-Matias TJ, Tufano MD, Kempf DJ.

Bioorg Med Chem Lett. 2012 Mar 15;22(6):2212-5. doi: 10.1016/j.bmcl.2012.01.096. Epub 2012 Feb 2.

PMID:
22342631
50.

The impact of snake bite on household economy in Bangladesh.

Hasan SM, Basher A, Molla AA, Sultana NK, Faiz MA.

Trop Doct. 2012 Jan;42(1):41-3. doi: 10.1258/td.2011.110137. Epub 2012 Jan 5.

PMID:
22223726

Supplemental Content

Support Center